NCT04799431 2023-05-09Neoantigen-Targeted Vaccine Combined With Anti-PD-1 Antibody for Patients With Stage IV MMR-p Colon and Pancreatic Ductal CancerSidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 1 Withdrawn